Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine and Lidocaine/Diphenhydramine in Vulvar Vestibulitis Syndrome
NCT00590590Phase 2Completed
- Sponsor
- Lumara Health
- Start
- Oct 2007
- Primary completion
- Jun 2009
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 2, randomised, double-blind trial in vulvar vestibulitis syndrome (VVS) comparing Lidocaine, Lidocaine/Diphenhydramine and Placebo (3 arms). Primary endpoint: Marinoff Dyspareunia Scale Score at 12 weeks. Started Oct 2007; status: completed.
02
Drugs
lidocainediphenhydramine
03
Conditions
vulvar vestibulitis syndrome (VVS)
Beyond the preview
Go deeper on NCT00590590.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00590590.